Status:
COMPLETED
Quantitative Sensory Testing in Chronic Pain Patients Undergoing Opioid Treatment and Opioid Tapering
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Conditions:
Analgesic Drug Dependence
Sensory Deficit
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Few studies have used quantitative sensory tests to study the effect of chronic opioid treatment on sensation. The investigators will test chronic pain patients who are on different MEDDs, normal volu...
Detailed Description
Death from drug overdoses reached a record high in 2014, with the majority involving an opioid. The United States government has labeled this an epidemic due to the progressive rise in opioid-involved...
Eligibility Criteria
Inclusion
- Patient age between 18 and 75
- History of chronic pain for at least 3 months
- Patients may have been selected for opioid taper by their pain physicians.
- Patients may or may not be on opioid therapy.
- They must have the ability to understand the protocol and provide voluntary, written, informed consent.
Exclusion
- Cancer pain
- Unstable medical conditions (including but not limited to history of myocardial infarction within the past year, autoimmune diseases, uncontrolled diabetes with hemoglobin A1C of greater than 10)
- Pregnancy
- Inability to adequately answer surveys
- History of substance abuse within 5 years
- Surgery within the past month
- Surgery planned during the next six months
- Use of systemic steroids.
Key Trial Info
Start Date :
December 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 18 2023
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT03375216
Start Date
December 22 2017
End Date
November 18 2023
Last Update
February 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Medical Branch
Galveston, Texas, United States, 77555